Digging deeper into those survival rate results, a finer point on the data would be to simplify it down to real numbers. At the time Nuvilex's clinical trials were conducted, Gemzar's historical data gave patients a median survival time of 5.5 months; whereas, Nuvilex's treatment during the two clinical trials resulted in a median survival time of 11 months.
Market Data 
Markets 
AI
